Clinical Trial Update: Sugammadex and Smoker's Neuromuscular Block [Phase 4]

View source ↗

Summary

Phase 4 clinical trial update investigating sugammadex in the context of neuromuscular blockade and smoking.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Neuromuscular Blockade
• Smoking-related Conditions

Drugs mentioned

• Sugammadex (sugammadex)

Snippet

Sponsor: Duzce University | Conditions: Neuromuscular Blockade, Smoking | Phase 4 | Status: COMPLETED